Edwards Lifesciences Corp

Carnegie Investment Counsel EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/23/2026

Shares

3,200

Value ($000)

273

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/23/2026	273	0.0%	3,200	12/31/2025
2025 Q3	10/16/2025	249	0.0%	3,200	9/30/2025
2025 Q2	7/31/2025	251	0.0%	3,210	6/30/2025
2025 Q1	5/6/2025	221	0.0%	3,200	3/31/2025
2024 Q4	1/15/2025	304	0.0%	4,100	12/31/2024
2024 Q3	10/10/2024	278	0.0%	4,220	9/30/2024
2024 Q2	7/22/2024	519	0.0%	5,620	6/30/2024
2024 Q1	5/6/2024	537	0.0%	5,620	3/31/2024
2023 Q4	1/30/2024	486	0.0%	6,370	12/31/2023
2023 Q3	10/11/2023	393	0.0%	5,669	9/30/2023
2023 Q2	8/4/2023	535	0.0%	5,669	6/30/2023
2023 Q1	4/20/2023	490	0.0%	5,919	3/31/2023
2022 Q4	1/24/2023	443	0.0%	5,933	12/31/2022
2022 Q3	10/14/2022	489	0.0%	5,919	9/30/2022
2022 Q2	8/2/2022	620	0.0%	6,519	6/30/2022
2021 Q4	1/21/2022	934	0.0%	7,209	12/31/2021
2021 Q3	10/8/2021	952	0.0%	8,409	9/30/2021
2021 Q2	7/16/2021	819	0.0%	7,909	6/30/2021
2021 Q1	4/12/2021	668	0.0%	7,984	3/31/2021
2020 Q4	2/8/2021	528	0.0%	5,784	12/31/2020
2020 Q3	10/13/2020	406	0.0%	5,085	9/30/2020
2020 Q2	7/9/2020	351	0.0%	5,085	6/30/2020
2020 Q1	5/8/2020	320	0.0%	1,695	3/31/2020
2019 Q4	2/13/2020	431	0.0%	1,848	12/31/2019